Engoren M, Luther G, Fenn-Buderer N
Department of Anesthesiology, St. Vincent Mercy Medical Center, Toledo, Ohio 43608, USA.
Anesth Analg. 2001 Oct;93(4):859-64. doi: 10.1097/00000539-200110000-00011.
Cardiac surgery is estimated to cost $27 billion annually in the United States. In an attempt to decrease the costs of cardiac surgery, fast-track programs have become popular. The purpose of this study was to compare the effects of three different opioid techniques for cardiac surgery on postoperative pain, time to extubation, time to intensive care unit discharge, time to hospital discharge, and cost. Ninety adult patients undergoing cardiac surgery were randomized to a fentanyl-based, sufentanil-based, or remifentanil-based anesthetic. Postoperative pain was measured at 30 min after extubation and at 6:30 AM on the first postoperative day. Pain scores at both times were similar in all three groups (P > 0.05). Median ventilator times of 167, 285, and 234 min (P > 0.05), intensive care unit stays of 18.8, 19.8, and 21.5 h (P > 0.05), and hospital stays of 5, 5, and 5 days (P > 0.05) for the Fentanyl, Sufentanil, and Remifentanil groups did not differ. Three patients needed to be tracheally reintubated: two in the Sufentanil group and one in the Fentanyl group. Median anesthetic costs were largest in the Remifentanil group ($140.54 [$113.54-$179.29]) and smallest in the Fentanyl group ($43.33 [$39.36-$56.48]) (P < or = 0.01), but hospital costs were similar in the three groups: $7841 (Fentanyl), $5943 (Sufentanil), and $6286 (Remifentanil) (P > 0.05). We conclude that the more expensive but shorter-acting opioids, sufentanil and remifentanil, produced equally rapid extubation, similar stays, and similar costs to fentanyl, indicating that any of these opioids can be recommended for fast-track cardiac surgery.
To conserve resources for cardiac surgery, fentanyl-, sufentanil-, and remifentanil-based anesthetics were compared for duration of mechanical ventilation, intensive care unit length of stay, hospital length of stay, and cost. The shorter-acting anesthetics, sufentanil and remifentanil, produced equally rapid extubation, similar stays, and similar costs to fentanyl; thus, any of these opioids can be recommended for fast-track cardiac surgery.
据估计,在美国每年心脏手术的花费为270亿美元。为了降低心脏手术成本,快速康复计划已变得流行起来。本研究的目的是比较三种不同的心脏手术阿片类技术对术后疼痛、拔管时间、重症监护病房出院时间、住院时间和成本的影响。90例接受心脏手术的成年患者被随机分为芬太尼麻醉组、舒芬太尼麻醉组或瑞芬太尼麻醉组。在拔管后30分钟和术后第一天上午6:30测量术后疼痛。三组在这两个时间点的疼痛评分相似(P>0.05)。芬太尼组、舒芬太尼组和瑞芬太尼组的中位呼吸机使用时间分别为167、285和234分钟(P>0.05),重症监护病房停留时间分别为18.8、19.8和21.5小时(P>0.05),住院时间均为5天(P>0.05),差异无统计学意义。3例患者需要再次气管插管:舒芬太尼组2例,芬太尼组1例。瑞芬太尼组的中位麻醉成本最高(140.54美元[113.54 - 179.29美元]),芬太尼组最低(43.33美元[39.36 - 56.48美元])(P≤0.01),但三组的住院成本相似:芬太尼组7841美元、舒芬太尼组5943美元、瑞芬太尼组6286美元(P>0.05)。我们得出结论,更昂贵但作用时间较短的阿片类药物舒芬太尼和瑞芬太尼,在拔管速度、住院时间和成本方面与芬太尼相当,表明这些阿片类药物中的任何一种都可推荐用于心脏手术快速康复。
为节约心脏手术资源,比较了芬太尼、舒芬太尼和瑞芬太尼麻醉在机械通气时间、重症监护病房住院时间、住院时间和成本方面的差异。作用时间较短的麻醉药物舒芬太尼和瑞芬太尼,在拔管速度、住院时间和成本方面与芬太尼相当;因此,这些阿片类药物中的任何一种都可推荐用于心脏手术快速康复。